• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Cyxone

Less than 1K followers
All
Research
Press releases
ShowingAll content types

Regulatory press release26.08.2024, 14.19

Cyxone AB announces last day of trading in BTA

Cyxone
Regulatory press release16.08.2024, 08.59

Cyxone AB publishes outcome of rights issue

Cyxone
Regulatory press release01.08.2024, 08.45

The subscription period in Cyxone's rights issue starts today

Cyxone

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release31.07.2024, 08.45

Cyxone AB publishes investment memorandum

Cyxone
Regulatory press release23.07.2024, 08.30

Cyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K

Cyxone
Press release15.07.2024, 08.42

Cyxone provides an update on its research and development program

Cyxone
Regulatory press release22.04.2024, 10.02

Kjell Stenberg new CEO in Cyxone AB

Cyxone
Press release28.03.2024, 11.52

BioStock: Cyxone comments on the clinical collaboration in the UK

Cyxone
Press release25.03.2024, 13.44

Cyxone enters important research collaboration

Cyxone
Press release05.03.2024, 09.42

BioStock: Cyxone's CEO gives a status update

Cyxone
Press release17.01.2024, 08.45

BioStock: Cyxone identifies target protein for rabeximod

Cyxone
Press release15.01.2024, 10.01

Cyxone reaches important milestone regarding mechanism of action

Cyxone
Press release20.11.2023, 09.22

Cyxone welcomes a renewed engagement by Professor Rikard Holmdahl as Scientific Advisor

Cyxone
Regulatory press release27.10.2023, 08.29

Cyxone: Interim Report 1 January to 30 September 2023

Cyxone
Regulatory press release09.10.2023, 08.38

Cyxone receives Intention to Grant from the European Patent Office for a unitary patent of T20K

Cyxone
Press release27.09.2023, 09.30

BioStock Investor Meeting: Cyxone

Cyxone
Regulatory press release30.08.2023, 08.32

Cyxone: Interim Report 1 January to 30 June 2023

Cyxone
Regulatory press release29.08.2023, 19.03

Cyxone revises strategy for commercial alignment targeting valuable market opportunities

Cyxone
Regulatory press release15.06.2023, 08.30

Cyxone appoints Urban Ottosson as new CFO

Cyxone
Press release31.05.2023, 14.00

Cyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K

Cyxone